Lymphoma imaging with a new technetium-99m labelled antibody, LL2

European Journal of Nuclear Medicine

Volumn 19, Issue 6, 1992, Pages 394-401

  Murthy, Sumathi ^a   Sharkey, Robert M ^a   Goldenberg, David M ^a   Lee, Robert E ^a   Pinsky, Carl M ^b   Hansen, Hans J ^b   Burger, Karen ^c   Swayne, Lawrence C ^d  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b IMMUNOMEDICS INC   (United States)

^c University of Medicine and Dentistry of New Jersey   (United States)

^d MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

Monoclonal antibody; NonHodgkin's lymphoma; Radioactive; Radionuclide studies

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LL2; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHODGKIN LYMPHOMA; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIBODIES, MONOCLONAL; HUMAN; LYMPHOMA, NON-HODGKIN; RADIOIMMUNODETECTION; REAGENT KITS, DIAGNOSTIC; SUPPORT, U.S. GOV'T, P.H.S.; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0026699371     PISSN: 03406997     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/BF00177365     Document Type: Article

References (26)

1. High-dose gallium imaging in lymphoma
2. The role of gallium-67 in the clinical evaluation of cancer
3. Abdomen CT And lymphography in the initial staging of NHL
4. Residual mass in lymphoma may not be residual disease (editorial)
5. Correlation of gallium uptake and degree of malignancy in non-Hodgkin's lymphoma (abstract)
6. Calculating the radiation dose to an organ
7. The role of CT in the initial staging and subsequent management of the lymphomas
8. Radioimmunodetection of human B-cell lymphomas with a radiolabeled tumor-specific monoclonal antibody (Lym-1)
9. Gallium-67 SPECT before and after treatment of lymphoma
10. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 113I or 99mTc
11. Targeting, dosimetry and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody
12. Gallium-67 imaging in monitoring lymphoma response to TV
13. Evaluating low and intermediate grade non-Hodgkin's lymphoma with gallium-67 and thallium-201 imaging (abstract)
14. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen
15. A revised scheme for calculating the absorbed dose from biologically distributed radionuclide
16. The staging of non-Hodgkin's lymphomas
17. Computed tomography of the abdomen and pelvis in NHL
18. Two new monoclonal antibodies, EPB-1 and EPB-2, reactive with human lymphoma
19. Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (antiCD37) antibody
20. Radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma using an 131-I-labeled monoclonal antibody: an Illinois Cancer Council study
21. Computed tomography in the diagnosis, staging and management of abdomen lymphoma
22. A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression
23. Monoclonal antibody image quantitation using the buildup factor (abstract)
24. Tumor and organ dosimetry for I-131-labeled LL2 (EPB-2) monoclonal antibody in patients with B-cell lymphoma
25. Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas
26. Characterization of lymphoma grade using thallium and gallium (abstract)